Older peoples' views on cardiovascular disease medication: a qualitative study.

Wallis, KA; Taylor, DA; Fanueli, EF; Saravanakumar, P; Wells, S

Older peoples' views on cardiovascular disease medication: a qualitative study.

Wallis, KA Taylor, DA Fanueli, EF Saravanakumar, P

Wells, S

Permalink

Publisher:: OXFORD UNIV PRESS
Publication Type:: Journal Article
Citation:: Fam Pract, 2022, 39, (5), pp. 897-902
Issue Date:: 2022-09-24

Closed Access

	Filename	Description	Size
	Older peoples’ views on cardiovascular disease medication_ a qualitative study.pdf		375.47 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wallis, KA
dc.contributor.author	Taylor, DA
dc.contributor.author	Fanueli, EF
dc.contributor.author	Saravanakumar, P https://orcid.org/0000-0001-6923-0355
dc.contributor.author	Wells, S
dc.date.accessioned	2023-06-14T04:08:37Z
dc.date.available	2023-06-14T04:08:37Z
dc.date.issued	2022-09-24
dc.identifier.citation	Fam Pract, 2022, 39, (5), pp. 897-902
dc.identifier.issn	0263-2136
dc.identifier.issn	1460-2229
dc.identifier.uri	http://hdl.handle.net/10453/170751
dc.description.abstract	BACKGROUND: There is increasing evidence for the potential benefits and harms of cardiovascular disease (CVD) medications in older people (>75 years) prompting updating of clinical guidelines. We explored the views of older people about CVD medication to inform guideline development. METHODS: Qualitative study using semistructured interviews and focus groups. An ethnically diverse group of community dwelling older people were purposefully recruited from northern New Zealand using flyers in primary care clinics, local libraries, social groups, and places of worship, and by word of mouth. Interviews and focus groups were digitally recorded, transcribed verbatim, and analysed using an iterative and inductive approach to thematic analysis. RESULTS: Thirty-nine participants from 4 ethnic groups were recruited (mean 74 years; range 61-91 years; Māori (7), South Asian (8), European (9), and Pasifika (15)). Most participants were taking CVD medication/s. Four main themes emerged: (i) emphasizing the benefits of CVD medication and downplaying the harms; (ii) feeling compelled to take medication; (iii) trusting "my" doctor; and (iv) expecting medication to be continued. CONCLUSION: Findings raise questions about older people's agency in decision-making regarding CVD medication. CVD risk management guidelines for older people could include strategies to support effective communication of the potential benefits and harms of CVD medication in older people, balancing life expectancy, and the expected duration of therapy.
dc.format	Print
dc.language	eng
dc.publisher	OXFORD UNIV PRESS
dc.relation.ispartof	Fam Pract
dc.relation.isbasedon	10.1093/fampra/cmab186
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1117 Public Health and Health Services
dc.subject.classification	Public Health
dc.subject.mesh	Aged
dc.subject.mesh	Asian People
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Focus Groups
dc.subject.mesh	Humans
dc.subject.mesh	Independent Living
dc.subject.mesh	Qualitative Research
dc.subject.mesh	Humans
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Focus Groups
dc.subject.mesh	Qualitative Research
dc.subject.mesh	Aged
dc.subject.mesh	Independent Living
dc.subject.mesh	Asian People
dc.subject.mesh	Aged
dc.subject.mesh	Asians
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Focus Groups
dc.subject.mesh	Humans
dc.subject.mesh	Independent Living
dc.subject.mesh	Qualitative Research
dc.title	Older peoples' views on cardiovascular disease medication: a qualitative study.
dc.type	Journal Article
utslib.citation.volume	39
utslib.location.activity	England
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
dc.date.updated	2023-06-14T04:08:36Z
pubs.issue	5
pubs.publication-status	Published
pubs.volume	39
utslib.citation.issue	5

Abstract:

BACKGROUND: There is increasing evidence for the potential benefits and harms of cardiovascular disease (CVD) medications in older people (>75 years) prompting updating of clinical guidelines. We explored the views of older people about CVD medication to inform guideline development. METHODS: Qualitative study using semistructured interviews and focus groups. An ethnically diverse group of community dwelling older people were purposefully recruited from northern New Zealand using flyers in primary care clinics, local libraries, social groups, and places of worship, and by word of mouth. Interviews and focus groups were digitally recorded, transcribed verbatim, and analysed using an iterative and inductive approach to thematic analysis. RESULTS: Thirty-nine participants from 4 ethnic groups were recruited (mean 74 years; range 61-91 years; Māori (7), South Asian (8), European (9), and Pasifika (15)). Most participants were taking CVD medication/s. Four main themes emerged: (i) emphasizing the benefits of CVD medication and downplaying the harms; (ii) feeling compelled to take medication; (iii) trusting "my" doctor; and (iv) expecting medication to be continued. CONCLUSION: Findings raise questions about older people's agency in decision-making regarding CVD medication. CVD risk management guidelines for older people could include strategies to support effective communication of the potential benefits and harms of CVD medication in older people, balancing life expectancy, and the expected duration of therapy.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/170751